Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence Shelley N. FacenteAngela M. ReiersenJeffrey D. Klausner Current Opinion Open access 01 December 2021 Pages: 2081 - 2089
Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A Nowell SolishJean CarruthersConor J. Gallagher Leading Article Open access 17 November 2021 Pages: 2091 - 2101
Cannabis-Based Medicines and Medical Cannabis in the Treatment of Nociplastic Pain Mary-Ann FitzcharlesFrank PetzkeWinfried Häuser Review Article 20 November 2021 Pages: 2103 - 2116
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update Dan ReynoldsMarin Kollef Review Article 07 November 2021 Pages: 2117 - 2131
Correction to: Regdanvimab: First Approval Yahiya Y. Syed Correction 16 November 2021 Pages: 2139 - 2139
Tisotumab Vedotin: First Approval Anthony Markham AdisInsight Report 08 November 2021 Pages: 2141 - 2147
Abrocitinib: First Approval Emma D. DeeksSean Duggan AdisInsight Report Open access 22 November 2021 Pages: 2149 - 2157
Correction to: Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections Yahiya Y. Syed Correction Open access 18 November 2021 Pages: 2167 - 2167
Correction to: Avatrombopag: A Review in Thrombocytopenia Anthony Markham Correction Open access 29 November 2021 Pages: 2169 - 2169